Pneumonia Testing Market Trends

Growth Drivers

• Rising Cases of COVID-19 – Some people with COVID-19 have pneumonia in both lungs. The condition associated with COVID-19 was formerly known as new-corona virus-associated pneumonia (NCIP). The coronavirus disease 2019 was dubbed COVID-19 by the World Health Organization (WHO). Around the world, there have been 8,385,450 reported cases of coronavirus disease 2019 (COVID-19) pneumonia in 2020, with 450,690 fatalities.

• Increasing Incidence of Hospital-acquired pneumonia (HAP) – HAP refers to pneumonia that appears more than 48 hours after being admitted to the hospital. Each year, hospitals in the U.S. witness up to 350,000 HAP events.

• Growing Geriatric Population – Aged individuals are more inclined to have long-term medical issues including heart disease or chronic obstructive pulmonary disease (COPD), which can raise the risk of pneumonia. By 2050, the global population over 60 is predicted to be close to 23%, and from 2020 to 2050, the number of people 80 or older is projected to treble, reaching 430 million.

• Advancement of POCT and Nucleic Acid Detection tests – The development of POCT (point of care test) and improved nucleic acid detection tests in pneumonia testing systems is another factor contributing to the market’s expansion. POCT is desirable owing to its ease of use, increased user approachability, earlier detection, and equivalent accuracy. Thus, POCT helps to achieve early diagnosis and treatment of epidemics as well as daily epidemic control.  For instance, Abbot itself provides more than 1.5 billion POCT devices globally each year.

Challenges

• Widespread Utilization of X-ray to Detect Pneumonia
• High Cost of the Testing Devices
• High Preference of Utilizing Traditional Approach to Identify Pneumonia-Causing Pathogens

The global pneumonia testing market is segmented and analyzed for demand and supply by application into hospitals, diagnostic laboratories, home care, and others. Out of these, the hospital segment is anticipated to hold the largest share by the end of 2031 on the back of the increasing number of hospitals and cutting-edge technologies provided by the hospitals. There were around 10,900 hospitals in Colombia, 8240 hospitals in Japan, and 6092 hospitals in the United States in 2020. The rising need for pneumonia testing elevates the number of hospitals grows and leads to the expansion of the segment.